JENNIFER GAMEZ: Open Payments
NPI 1639838329 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,883 in 101 payments from 17 companies in 2025. Trend: 2023 $1,495 · 2024 $1,544 · 2025 $1,883
Food & beverage: $1,784Education: $99
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $368 |
| E.R. Squibb & Sons, L.L.C. | 22 | $268 |
| Regeneron Healthcare Solutions, Inc. | 10 | $216 |
| Amgen Inc. | 8 | $177 |
| ABBVIE INC. | 13 | $170 |
| Novartis Pharmaceuticals Corporation | 7 | $136 |
| Lilly USA, LLC | 6 | $119 |
| REVANCE THERAPEUTICS, INC. | 2 | $99 |
| Janssen Biotech, Inc. | 5 | $76 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $67 |
Products named: Bimzelx, Sotyktu, DUPIXENT, OTEZLA, DAXXIFY, TALTZ, TREMFYA, RINVOQ.
Industry payments across TX — which companies pay providers there.
